SELLAS Life Sciences Group, Inc. (SLS)
7.08
-0.34
(-4.58%)
USD |
NASDAQ |
May 15, 16:00
7.13
+0.05
(+0.71%)
After-Hours: 20:00
SELLAS Life Sciences Group Total Assets (Quarterly) : 114.18M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Rezolute, Inc. | 125.46M |
| Krystal Biotech, Inc. | 1.397B |
| Spero Therapeutics, Inc. | 59.02M |
| Recursion Pharmaceuticals, Inc. | 1.340B |
| Whitehawk Therapeutics, Inc. | 127.23M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.765M |
| Shareholders Equity (Quarterly) | 107.41M |
| Debt to Equity Ratio | 0.0081 |
| Current Ratio | 17.22 |
| Net Debt Paydown Yield | 0.00% |